ATORX — Alligator Bioscience AB Share News
0.000.00%
Last trade - 00:00- SEK105.65m
- SEK105.06m
- SEK0.51m
Brief: Orion Corporation And Alligator Bioscience Enter Research Agreement
Brief: Alligator Bioscience And Orion Corporation Enter Research Agreement
Brief: Alligator Bioscience Q2 Operating Loss At SEK 34.5 Mln
Brief: Alligator Bioscience And Scandion Oncology Present Promising Preclinical Data
Brief: Alligator Bioscience And BioArctic Enter Into Research Collaboration
Brief: Alligator Bioscience Q1 Operating Loss Narrows To SEK 32.5 Mln
Brief: Alligator Bioscience Names Anders Ekblom Chairman Of Board
Brief: Alligator Bioscience And MacroGenics Enter Into Research Collaboration
Brief: Alligator Bioscience Postpones The Annual General Meeting To June 1, 2021
Brief: Alligator Bioscience Appoints Søren Bregenholt As New CEO
Brief: Alligator Bioscience Presents New Preclinical Data At AACR
Brief: Alligator Bioscience Q4 Operating Loss Narrows To SEK 34.1 Million
Brief: Alligator Bioscience Q4 Operating Loss Narrows To SEK 34.1 Mln
Brief: Alligator Bioscience's Rights Issue Oversubscribed
Brief: Alligator Carries Out A Fully Guaranteed Rights Issue Of About SEK 86 Mln
Brief: Alligator Bioscience: Approved IND For CD40-Targeting Antibody Mitazalimab
Brief: Alligator And Aptevo To Initiate Phase I Clinical Development
Brief: Predicted Therapeutic Range Dose Levels Reached In Ator-1017 Phase I
Brief: Alligator Bioscience AB - Q3 Operating Result at Sek -30.6 mln